Curis, Inc. (CRIS)
0.9065
+0.06
(+6.65%)
USD |
NASDAQ |
Nov 06, 16:00
0.8013
-0.11
(-11.61%)
After-Hours: 20:00
Curis Price to Book Value : 0.3763 for Nov. 6, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 06, 2026 | 0.3763 |
| November 05, 2026 | 0.3529 |
| November 04, 2026 | 0.4608 |
| November 03, 2026 | 0.2964 |
| November 02, 2026 | 0.2744 |
| October 30, 2026 | 0.2491 |
| October 29, 2026 | 0.2277 |
| October 28, 2026 | 0.1885 |
| October 27, 2026 | 0.1671 |
| October 26, 2026 | 0.1566 |
| October 23, 2026 | 0.1604 |
| October 22, 2026 | 0.1681 |
| October 21, 2026 | 0.1627 |
| October 20, 2026 | 0.1659 |
| October 19, 2026 | 0.1584 |
| October 16, 2026 | 0.169 |
| October 15, 2026 | 0.2109 |
| October 14, 2026 | 0.249 |
| October 13, 2026 | 0.2553 |
| October 12, 2026 | 0.267 |
| October 09, 2026 | 0.2786 |
| October 08, 2026 | 0.2945 |
| October 07, 2026 | 0.3058 |
| October 06, 2026 | 0.3109 |
| October 05, 2026 | 0.3275 |
| Date | Value |
|---|---|
| October 02, 2026 | 0.3335 |
| October 01, 2026 | 0.3448 |
| September 30, 2026 | 0.3483 |
| September 29, 2026 | 0.3441 |
| September 28, 2026 | 0.3451 |
| September 25, 2026 | 0.3445 |
| September 24, 2026 | 0.365 |
| September 23, 2026 | 0.3952 |
| September 22, 2026 | 0.4151 |
| September 21, 2026 | 0.4046 |
| September 18, 2026 | 0.4151 |
| September 17, 2026 | 0.4525 |
| September 16, 2026 | 0.4649 |
| September 15, 2026 | 0.4691 |
| September 14, 2026 | 0.4649 |
| September 11, 2026 | 0.4691 |
| September 10, 2026 | 0.4815 |
| September 09, 2026 | 0.4981 |
| September 08, 2026 | 0.5272 |
| September 04, 2026 | 0.5604 |
| September 03, 2026 | 0.5687 |
| September 02, 2026 | 0.5729 |
| September 01, 2026 | 0.5895 |
| August 31, 2026 | 0.6185 |
| August 28, 2026 | 0.6185 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 17.35 |
| Anika Therapeutics, Inc. | 1.416 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 0.941 |
Price to Book Value Related Metrics
| PS Ratio | 0.2456 |
| Price | 0.9065 |
| Earnings Yield | -1.58K% |
| Market Cap | 1.767M |